Search results
Results from the WOW.Com Content Network
Amyris, Inc. is a synthetic biotechnology and renewable chemical company headquartered in Emeryville, California. ... Draths Corporation, for $7 million in stock. [6]
Shares of bioscience firm Amyris (AMRS) skyrocketed more than 70% on Tuesday after the company announced a collaboration deal focused on developing, licensing, and commercializing cannabinoid ...
The stock of Amyris (NAS:AMRS, 30-year Financials) is estimated to be significantly overvalued, according to GuruFocus Value calculation.
Investors can now consider renewable products company Amyris (NASDAQ:AMRS) as a "marijuana stock." The Emeryville, California-based firm signed a deal to license cannabinoid products. This sent ...
The stock of Amyris (NAS:AMRS, 30-year Financials) is estimated to be significantly overvalued, according to GuruFocus Value calculation.
Zymergen was founded in 2013. [5] by investment banker Joshua Hoffman, biophysicist Zach Serber, and biochemist Jed Dean. [6]All three met while working at Amyris, Inc. [7] The company uses machine learning and artificial intelligence to study and modify microbes which ferment carbon [6] to produce chemicals used in manufacturing consumer goods and pharmaceuticals. [8]
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Amyris is hold, with an average price target of $3.50. Is Amyris the right energy stock for you? Read about a ...
Amyris Fuels, LLC, is a wholly owned subsidiary of Amyris, a business unit formed to develop a network for supplying and distributing renewable fuels. [1] The company sources current biofuels , such as ethanol , from international producers and brings them to market.